McCurry Kenneth R
Department of Cardiothoracic Surgery, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, J4-1, Cleveland, OH 44195, USA.
Crit Care Clin. 2019 Jan;35(1):1-9. doi: 10.1016/j.ccc.2018.08.005. Epub 2018 Oct 25.
Lung transplantation, heart transplantation, and heart-lung transplantation are life-saving treatment options for patients with lung and/or cardiac failure. Evolution in these therapies over the past several decades has led to better outcomes with application to more patients. The complexity and severity of illness of patients in the pretransplant phase has steadily increased, making posttransplant intensive care unit management more difficult. Despite these factors and the pervasive complications of immunosuppressive therapy, outcomes continue to improve.
肺移植、心脏移植和心肺移植是治疗肺和/或心力衰竭患者的挽救生命的治疗选择。在过去几十年中，这些治疗方法的不断发展使得更多患者能够从中受益，取得了更好的治疗效果。移植前阶段患者疾病的复杂性和严重性不断增加，使得移植后重症监护病房的管理更加困难。尽管存在这些因素以及免疫抑制治疗普遍存在的并发症，但治疗效果仍在不断改善。
